Skip to main content
. Author manuscript; available in PMC: 2023 Feb 1.
Published in final edited form as: Biomed Pharmacother. 2021 Dec 22;146:112571. doi: 10.1016/j.biopha.2021.112571

Table 3.

Peak changes in ventilatory parameters elicited by fentanyl in the three treatment groups

Parameter Vehicle L-NAME D-NAME

Frequency, breaths/min −25 ± 7* −39 ± 5* −24 ± 4*
Tidal Volume (TV), ml −46 ± 5* −47 ± 7* −45 ± 4*
Minute Ventilation, ml/min −44 ± 4* −68 ± 3*, −43 ± 5*
Inspiratory time (Ti), sec +54 ± 14* +74 ± 9* +53 ± 8*
Expiratory time (Te), sec +131 ± 21* +312 ± 46*, +133 ± 17*
End inspiratory pause, msec +112 ± 13* +139 ± 12* +107 ± 15*
End expiratory pause, msec +1102 ± 136* +1702 ± 138*, +1092 ± 109*
Peak inspiratory flow, ml/sec −51 ± 4* −55 ± 6* −52 ± 5*
Peak expiratory flow, ml/sec −41 ± 6* −51 ± 6* −43 ± 5*
EF50, ml/sec +118 ± 12* +105 ± 16* +113 ± 13*
Relaxation time (RT), sec −36 ± 6* −36 ± 3* −33 ± 4*
Apneic pause, (Te/RT)-1 +365 ± 64* +752 ± 149*, +357 ± 44*
TV/Ti, ml/sec −51 ± 4* −58 ± 4* −53 ± 7*
TV/Te, ml/sec −72 ± 6* −85 ± 5* −78 ± 9*
NEBI, % +345 ± 23 +724 ± 83*, +319 ± 27*
NEBI/Freq, %/(breaths/min) +352 ± 62* +1296 ± 62*, +355 ± 51*

NEBI, non-eupneic breathing index. The data are presented as mean ± SEM. There were 6 rats in each of the vehicle-treated, and L-NAME- and D-NAME-treated groups.

*

P < 0.05, significant change from pre-value.

P < 0.05, L-NAME-treated versus vehicle-treated.